Get the Stockscreener App
0.8532
1.26%
0.0106
After Hours:
.85
-0.0032
-0.38%
InspireMD Inc. stock is traded at $0.8532, with a volume of 30,329.
It is up +1.26% in the last 24 hours and up +18.52% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$0.8426
Open:
$0.835
24h Volume:
30,329
Relative Volume:
0.32
Market Cap:
$39.96M
Revenue:
$10.85M
Net Income/Loss:
$-51.31M
P/E Ratio:
-1.1577
EPS:
-0.737
Net Cash Flow:
$-40.15M
1W Performance:
+0.38%
1M Performance:
+18.52%
6M Performance:
-47.01%
1Y Performance:
-65.03%
1-Day Range:
$0.825
$0.8986
1-Week Range:
$0.825
$0.9284
52-Week Range:
$0.63
$2.565
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
0.8532 | 42.15M | 10.85M | -51.31M | -40.15M | -0.737 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-26 | Initiated | Maxim Group | Buy |
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
InspireMD announces inducement grants - Medical Buyer
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Inc. (NSPR) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - valueresearchonline.com
InspireMD Inc. Series B Warrants (NSPRZ) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InspireMD Inc. Series B Warrants (NSPRZ) Peer Comparison – Compare with Others - valueresearchonline.com
InspireMD Earnings Call: Recall Pain, Regulatory Potential - TipRanks
InspireMD Inc. Series B Warrants (NSPRZ) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate - Sci-Tech Today
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026 - Medical Buyer
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com South Africa
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com Nigeria
InspireMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
symbol__ Stock Quote Price and Forecast - CNN
InspireMD reports Q2 2026 revenue $1.77M, net loss $14.3M; cash & marketable securities $30.4M - TradingView
InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative
InspireMD (NSPR) recall turns U.S. sales negative — and deepens quarterly loss - Stock Titan
InspireMD Q2 Operating Expenses USD 13.671 Mi - Moomoo
InspireMD Reports Second Quarter 2026 Financial Results - The Manila Times
InspireMD (NSPR) Surges 16.97% to $0.98, Pushing Toward Key ResistanceSentiment Shift - vinanet.vn
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Moomoo
InspireMD (NSPR) grows revenue 56% but flags going concern and Nasdaq risk - Stock Titan
InspireMD Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
InspireMD (NSPR) Dips 3.26% to $0.83, Pressing Against Key SupportVolatility Smirk - vinanet.vn
InspireMD (NSPR.US) is scheduled to release its financial report on August 17. - Moomoo
InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InspireMD grants 91,161 restricted shares to new employees - scanx.trade
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set - scanx.trade
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan
Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - webull.com
InspireMD Approves 221,666 Restricted Shares for New Hire - Stock Titan
InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine
InspireMD (NSPR) Gains 5.73% to $0.72, Pressing Toward Key Resistance at $0.76BPI Reversal - vinanet.vn
InspireMD (NSPR) Slides 3.68% to $0.65 as Key Support HoldsBullish Pattern Stocks - vinanet.vn
Piper Sandler Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD appoints Kathleen Kennedy as SVP of global sales By Investing.com - Investing.com Nigeria
Medical-device sales leader with more than 30 years returns to InspireMD - Stock Titan
InspireMD Eliminates Chief Commercial Officer Position - The Globe and Mail
InspireMD, Inc. (NASDAQ: NSPR) eliminates chief commercial officer position - Stock Titan
NSPR|InspireMD Inc|Price:0.650|Chg%:-0.024 - TradingKey
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):